Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer
Completed · Early Phase 1
Conditions studied: Breast Cancer
In brief
RATIONALE: Vaccines made from peptides may help the body build an effective immune response to kill tumor cells. It is not yet known which vaccine is most effective in treating breast cancer. PURPOSE: This randomized clinical trial is studying the side effects of three different vaccine therapies and comparing the vaccines to see how well they work in treating patients with previously treated stage II or stage III breast cancer.
Key facts
- Study ID
- NCT00640861
- Run by
- Mayo Clinic
- People needed
- 45
- Starts
- 2008-08-28
- Expected to finish
- 2015-04-21
- Last updated by the study team
- 2018-10-31
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic in Arizona — Scottsdale, Arizona, United States
- Mayo Clinic in Florida — Jacksonville, Florida, United States
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.